Protease-resistant glucagon like peptide-1 analogs with long-term anti-diabetes type 2 activity

  • Hongjian Li
  • Cindy X Zhou
  • Zhengding Su
Part of the Advances in Experimental Medicine and Biology book series (volume 611)


Peptide Bond Peptide Analog Ethyl Bond Oral Glucose Challenge Protease Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was partially supported by Guangdong Key Laboratory of Biopharmacy (2006B60119) and Guangzhou Scientific and Technological Fund (2006Z3-E4152) to H. J. L and Z.D.S.


  1. 1.
    Gallwitz, B. (2006) Minerva Endocrinol. 31, 133–147.Google Scholar
  2. 2.
    Arulmozhi, D. K. & Portha, B. (2006) Eur J Pharm Sci. 28, 96–108.CrossRefGoogle Scholar
  3. 3.
    Trebbien, R.; Klarskov, L.; Olesen, M.; Holst, J. J.; Carr, R. D. & Deacon, C. F. (2004) Am. J. Physiol. Endocrinol. Metab., 287, 431–438.CrossRefGoogle Scholar
  4. 4.
    Eng, J.; Kleinman, W. A.; Singh, L.; Singh, G. & Raufman, J. P. (1992) J. Biol. Chem. 267, 7402–7408.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Hongjian Li
    • 1
  • Cindy X Zhou
    • 2
  • Zhengding Su
    • 2
    • 3
  1. 1.Depart. of BiotechnologyJinan UniversityGuangzhouChina
  2. 2.Amersino BiodevelopKitchener
  3. 3.Department of ChemistryUniversity of WaterloowaterlooCanada

Personalised recommendations